4 August 2021
Drug blocking coronavirus infection developed

Drug blocking coronavirus infection developed

From Ohio State University A research team has developed a drug for the new type of coronavirus that contains small protein fragments that can prevent it from infecting cells. The team is looking for ways to turn the potential treatment method they developed into a system that can be applied by everyone.

Spray solution to prevent coronavirus spread

At Ohio State University very similar to neutralizing antibodies resulting from a coronavirus infection or vaccination, pepdids by binding to spike proteins through the virus ACE2 to integrate into receptors and cells infected developed a drug to prevent it from becoming Pepdids cells of the virus in the nasal cavity and lung infected a nasal spray to stop the virus from happening spike protein It can be used to develop other drugs that may block.

Coronavirus Stating that it must infect the cells in order to survive, the researchers ACE2 He said it attaches to its receptor and then begins to replicate inside the cell to replicate itself. At the head of researchers name the one Amit Sharma, also its main purposes SARS-CoV-2’nin pepditlere every time you touch inactive This is because it depends on what the virus must already use to bind to the cell. Therefore, he stated that the virus must be reached from outside the cell.


The team tested several peptides in lab experiments, and two of the candidates to control groups found that it effectively reduced infection by comparison. On the other hand this peptides just like nasal sprays COVID-19 It can also be used to develop not treatments but other agents that can neutralize the virus. As a method, aerosol It seems the most logical to neutralize the virus before it reaches the human body by placing it in surface disinfectants.

Leave a Reply

Your email address will not be published. Required fields are marked *